The global Aphakia Market is expected to grow at a CAGR of 9.21% from 2017 to 2025. Aphakia is the absence of the lens of the eye, due to surgical removal, a perforating wound or ulcer, or congenital anomaly. The increasing demand for ophthalmic medical services and healthcare solutions, the market is driven in a positive growth trend, all over the globe at a high CAGR.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing prevalence of Ophthalmic Disorders
1.2 Growing Fund in Healthcare Sector
1.3 Growing Geriatric population
2. Market Restraints
2.1 High Cost of Surgeries
2.2 Lack of treatment availability ad professionals
Market Segmentation:
1. Global Aphakia Market, By Treatment:
1.1 Spectacles
1.1.1 +10D
1.1.2 +3-4D
1.1.3 Other
1.2 Contact Lenses
1.3 Intraocular Lens Implantation
1.4 Refractive Surgery
1.4.1 Keratophakia
1.4.2 Epikeratophakia
1.4.3 Hyperopic LASIK
1.5 Others
2. Global Aphakia Market, By Cause:
2.1 Congenital Aphakia,
2.2 Surgical Aphakia,
2.3 Acquired Aphakia
2.3.1 Traumatic Extrusion
2.3.2 Posterior Dislocation
2.3.3 Couching
2.3.4 Other
2.4 Others
3. Global Aphakia Market, By End User:
3.1 Hospitals
3.2 Ophthalmic Clinics
3.3 Others
4. Global Aphakia Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Johnson & Johnson Services, Inc.
2. Ophtec BV
3. Novartis
4. Valeant
5. ZEISS International
6. Rayner
7. Bohus BioTech AB
8. Lifecore Biomedical
9. LLC, Aetna Inc.
10. The Cooper Companies Inc.
11. Menicon Co., Ltd.
12. Labtician Ophthalmics, Inc.
13. Artificial Eye Co.
14. Contact Fill
15. ALLERGAN
16. MJS Lens Technology Ltd.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Aphakia Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL APHAKIA MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL APHAKIA MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL APHAKIA MARKET, BY TREATMENT
5.1 Overview
5.2 Spectacles
5.2.1 +10D
5.2.2 +3-4D
5.2.3 Other
5.3 Contact Lenses
5.4 Intraocular Lens Implantation
5.5 Refractive Surgery
5.5.1 Keratophakia
5.5.2 Epikeratophakia
5.5.3 Hyperopic LASIK
5.6 Others
6 GLOBAL APHAKIA MARKET, BY CAUSE
6.1 Overview
6.2 Congenital Aphakia,
6.3 Surgical Aphakia,
6.4 Acquired Aphakia
6.4.1 Traumatic Extrusion
6.4.2 Posterior Dislocation
6.4.3 Couching
6.4.4 Other
6.5 Others
7 GLOBAL APHAKIA MARKET, BY END USER
7.1 Overview
7.2 Hospitals
7.3 Ophthalmic Clinics
7.4 Others
8 GLOBAL APHAKIA MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025
9 GLOBAL APHAKIA MARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 Johnson & Johnson Services, Inc.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Ophtec BV
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Novartis
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 ZEISS International
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Rayner
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Bohus BioTech AB
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Lifecore Biomedical
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Aetna Inc.
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 The Cooper Companies Inc.
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Menicon Co., Ltd.
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
10.11 Labtician Ophthalmics, Inc.
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments
10.12 Artificial Eye Co.
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments
10.13 Contact Fill
10.13.1 Overview
10.13.2 Financial Performance
10.13.3 Product Outlook
10.13.4 Key Developments
10.14 ALLERGAN
10.14.1 Overview
10.14.2 Financial Performance
10.14.3 Product Outlook
10.14.4 Key Developments
10.15 MJS Lens Technology Ltd.
10.15.1 Overview
10.15.2 Financial Performance
10.15.3 Product Outlook
10.15.4 Key Developments
11 Appendix
11.1 Related Reports
Aphakia is a condition that involves not having an eye lens. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Aphakia Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and compre...
The research team projects that the Aphakia market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.
The prime objective of this report is to help the user understan...
The Aphakia Market report offers perceptive information regarding drivers, restraints, opportunities, and trends of the Aphakia Market. With the use of historic data from (period), the Aphakia Market report offers Y-o-Y growth and CAGR until 2026. The insightful data offered in the report ma...
Aphakia is a condition that involves not having an eye lens. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Aphakia Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and compre...
The global Aphakia Market is expected to grow at a CAGR of 9.21% from 2017 to 2025. Aphakia is the absence of the lens of the eye, due to surgical removal, a perforating wound or ulcer, or congenital anomaly. The increasing demand for ophthalmic medical services and healthcare solutions, the market ...